N-Glycans on the short ectodomain of the primary envelope glycoprotein play a major role in the polyclonal activation of B cells by lactate dehydrogenase-elevating virus

References

1. Ahmed R., Oldstone M. B. A. 1984; Mechanisms and biological implications of virus-induced B-cell activation. In Concepts in Viral Pathogenesis pp 231–238 Edited by Notkins A. L., Oldstone M. B. A. New York: Springer Verlag;
   [Google Scholar]
2. Anderson G. W., Rowland R. R. R., Palmer G. A., Even C., Plagemann P. G. W. 1995; Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers concomitant with polyclonal activation of B cells. Journal of Virology 69:5177–5185
   [Google Scholar]
3. Cafruny W. A., Chan S. P. K., Harty J. T., Yousefi S., Kowalchyk K., McDonald D., Foreman B., Budweg G., Plagemann P. G. W. 1986a; Antibody response of mice to lactate dehydrogenase-elevated virus during infection and immunization with inactivated virus. Virus Research 5:357–375
   [Google Scholar]
4. Cafruny W. A., Heruth D. P., Jaqua M. J., Plagemann P. G. W. 1986b; Immunoglobulins that bind to uncoated ELISA plates: appearance in mice during infection with lactate dehydrogenase-elevating virus and in human anti-nuclear antibody-positive sera. Journal of Medical Virology 19:175–186
   [Google Scholar]
5. Cafruny W. A., Bradley S. E., Rowland R. R. R. 1999; Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice. Viral Immunology 12:163–173
   [Google Scholar]
6. Chen Z., Plagemann P. G. W. 1997; Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT–PCR assays and its removal from the tumor cells. Journal of Virological Methods 65:227–236
   [Google Scholar]
7. Chen Z., Rowland R. R. R., Anderson G. W., Palmer G. A., Plagemann P. G. W. 1997; Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection. Journal of Virology 71:2910–2920
   [Google Scholar]
8. Chen Z., Li K., Rowland R. R. R., Anderson G. W., Plagemann P. G. W. 1998; Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired ability for high viremic persistent infection. Journal of Neurovirology 4:560–568
   [Google Scholar]
9. Chen Z., Li K., Rowland R. R. R., Plagemann P. G. W. 1999; Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice. Journal of Neurovirology 5:200–208
   [Google Scholar]
10. Chen Z., Li K., Plagemann P. G. W. 2000; Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein. Virology 266:88–98
    [Google Scholar]
11. Coutelier J.-P., van Snick J. 1985; Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. European Journal of Immunology 15:250–255
    [Google Scholar]
12. Coutelier J.-P., van der Logt J. T. M., Haesen F. W. A., Vink A., van Snick J. 1988; Virally induced modulation of murine IgG antibody subclasses. Journal of Experimental Medicine 168:2373–2378
    [Google Scholar]
13. Coutelier J.-P., Coulie P. G., Wauters P., Heremans H., van der Logt J. T. M. 1990; In vivo polyclonal B-lymphocyte activation elicited by murine viruses. Journal of Virology 64:5383–5388
    [Google Scholar]
14. Coutelier J.-P., van Broek J., Wolf S. F. 1995; Interleukin-12 gene expression after viral infection in the mouse. Journal of Virology 69:1955–1958
    [Google Scholar]
15. Even C., Hu B., Erickson L., Plagemann P. G. W. 1992; Correlation between levels of immunoglobulins and immune complexes in plasma of C57BL/6 and C57L/J mice infected with MAIDS retrovirus. Viral Immunology 5:39–50
    [Google Scholar]
16. Faaberg K. S., Plagemann P. G. W. 1995; The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography. Virology 212:512–525
    [Google Scholar]
17. Faaberg K. S., Plagemann P. G. W. 1997; ORF3 of lactate dehydrogenase-elevating virus encodes a soluble, nonstructural, highly glycosylated, and antigenic protein. Virology 227:245–251
    [Google Scholar]
18. Godeny E. K., Chen L., Kumar S. N., Methven S. L., Koonin E. V., Brinton M. A. 1993; Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV). Virology 194:585–596
    [Google Scholar]
19. Harty J. T., Chan S. P. K., Plagemann P. G. W. 1987; Characteristics of monoclonal antibodies to the lactate dehydrogenase-elevating virus. Intervirology 27:53–60
    [Google Scholar]
20. Hu B., Even C., Plagemann P. G. W. 1992; Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: relationship to IgG2a and IgG2b-specific polyclonal activation of B cells. Viral Immunology 5:27–38
    [Google Scholar]
21. Janeway C. A., Travers P., Walport M., Capra J. D. 1999 Immunobiology, 4th edn. pp 321–323 Garland Publishing;
22. Li X., Hu B., Harty J. T., Even C., Plagemann P. G. W. 1990; Polyclonal activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4⁺ lymphocytes. Viral Immunology 3:273–288
    [Google Scholar]
23. Li K., Chen Z., Plagemann P. G. W. 1998; The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. Virology 242:239–245
    [Google Scholar]
24. Li K., Chen Z., Plagemann P. G. W. 1999; High frequency genetic recombination of an arterivirus, lactate dehydrogenase-elevating virus, in mice and evolution of neuropathogenic variants. Virology 258:73–83
    [Google Scholar]
25. Li K., Schuler T., Chen Z., Glass G. E. G., Childs J. E., Plagemann P. G. W. 2000; Isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization. Virus Research (in press
    [Google Scholar]
26. Notkins A. L., Mergenhagen S. E., Rizzo A. A., Scheele C., Waldmann T. A. 1966; Elevated γ globulin and increased antibody production in mice infected with lactic dehydrogenase virus. Journal of Experimental Medicine 123:347–356
    [Google Scholar]
27. Palmer G. A., Kuo L., Chen Z., Faaberg K. S., Plagemann P. G. W. 1995; Sequence of genome of lactate dehydrogenase-elevating virus: heterogeneity between strains P and C. Virology 209:637–642
    [Google Scholar]
28. Plagemann P. G. W. 1996; Lactate dehydrogenase-elevating virus and related viruses. In Fields Virology pp 1105–1120 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
29. Plagemann P. G. W., Rowland R. R. R., Even C., Faaberg K. S. 1995; Lactate dehydrogenase-elevating virus – an ideal persistent virus?. Seminars in Immunopathology 17:167–186
    [Google Scholar]
30. Rowland R. R. R., Even C., Anderson G. W., Chen Z., Hu B., Plagemann P. G. W. 1994; Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation. Journal of General Virology 75:1071–1081
    [Google Scholar]